Sr. Dir., Clinical Development
Tolmar, Inc.
Monmouth Junction, New Jersey
Raja Velagapudi is currently Senior Director, Clinical Development, Tolmar Inc., US. Raja has received his Master of Pharmacy (1976) from Andhra University (India), Masters in Pharmaceutics (1978) from Duquesne University, and his doctorate in Biopharmaceutics (1983) from University of Texas at Austin. He worked at the FDA as a reviewer for 9 years in different capacities in the Division of Biopharmaceutics (Office of Clinical Pharmacology). He worked in the brand pharmaceuticals (Ciba-Geigy/Knoll Pharmaceuticals/Abbott) for 13 years in clinical pharmacology and pharmacokinetics. At Barr Laboratories/Teva, he worked on the clinical development of generics drugs and biosimilars for 7 years. At Sandoz, he worked in clinical development of small molecules through business development and in licensing for the last 10 years as an Executive Director. He has over 20 publications and presented numerous abstracts at scientific meetings.
Raja is active in AAPS and served over the years: Past Chair of Nutraceuticals focus group, Membership Strategic Oversight Committee, Generic Pharmaceuticals focus group and incoming Chair for the Regulatory Sciences Community (2022-23). He has been active participant of the FDA GDUFA Generic Drug Sciences and Research Workshops over the years and served as a panelist and a speaker for the Modeling and Simulation sessions.
Disclosure information not submitted.
Monday, October 17, 2022
12:30 PM – 1:15 PM ET
Tuesday, October 18, 2022
2:30 PM – 3:30 PM ET
Wednesday, October 19, 2022
9:00 AM – 10:00 AM ET
Wednesday, October 19, 2022
9:00 AM – 9:30 AM ET